The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial
<p>Abstract</p> <p>Background</p> <p>The objective of this article is to describe the design of a study to evaluate the clinical and economic effects of a Disease Management model on functional health, quality of care and quality of life of persons living in homes for t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-07-01
|
| Series: | BMC Health Services Research |
| Online Access: | http://www.biomedcentral.com/1472-6963/8/143 |
| _version_ | 1818347727763800064 |
|---|---|
| author | Ribbe Miel W Frijters Dinnus H van Hout Hein PJ Boorsma Marijke Nijpels Giel |
| author_facet | Ribbe Miel W Frijters Dinnus H van Hout Hein PJ Boorsma Marijke Nijpels Giel |
| author_sort | Ribbe Miel W |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>The objective of this article is to describe the design of a study to evaluate the clinical and economic effects of a Disease Management model on functional health, quality of care and quality of life of persons living in homes for the elderly.</p> <p>Methods</p> <p>This study concerns a cluster randomized controlled clinical trial among five intervention homes and five usual care homes in the North-West of the Netherlands with a total of over 500 residents. All persons who are not terminally ill, are able to be interviewed and sign informed consent are included. For cognitively impaired persons family proxies will be approached to provide outcome information. The Disease Management Model consists of several elements: (1) Trained staff carries out a multidimensional assessment of the patients functional health and care needs with the interRAI Long Term Care Facilities instrument (LTCF). Computerization of the LTCF produces immediate identification of problem areas and thereby guides individualized care planning. (2) The assessment outcomes are discussed in a Multidisciplinary Meeting (MM) with the nurse, primary care physician, nursing home physician and Psychotherapist and if necessary other members of the care team. The MM presents individualized care plans to manage or treat modifiable disabilities and risk factors. (3) Consultation by an nursing home physician and psychotherapist is offered to the frailest residents at risk for nursing home admission (according to the interRAI LTCF). Outcome measures are Quality of Care indicators (LTCF based), Quality Adjusted Life Years (Euroqol), Functional health (SF12, COOP-WONCA), Disability (GARS), Patients care satisfaction (QUOTE), hospital and nursing home days and mortality, health care utilization and costs.</p> <p>Discussion</p> <p>This design is unique because no earlier studies were performed to evaluate the effects and costs of this Disease Management Model for disabled persons in homes for the elderly on functional health and quality of care.</p> <p>Trail registration number</p> <p>ISRCTN11076857</p> |
| first_indexed | 2024-12-13T17:38:46Z |
| format | Article |
| id | doaj.art-59a1ee30de6f4bcba4550f6ab21facec |
| institution | Directory Open Access Journal |
| issn | 1472-6963 |
| language | English |
| last_indexed | 2024-12-13T17:38:46Z |
| publishDate | 2008-07-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Health Services Research |
| spelling | doaj.art-59a1ee30de6f4bcba4550f6ab21facec2022-12-21T23:36:50ZengBMCBMC Health Services Research1472-69632008-07-018114310.1186/1472-6963-8-143The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trialRibbe Miel WFrijters Dinnus Hvan Hout Hein PJBoorsma MarijkeNijpels Giel<p>Abstract</p> <p>Background</p> <p>The objective of this article is to describe the design of a study to evaluate the clinical and economic effects of a Disease Management model on functional health, quality of care and quality of life of persons living in homes for the elderly.</p> <p>Methods</p> <p>This study concerns a cluster randomized controlled clinical trial among five intervention homes and five usual care homes in the North-West of the Netherlands with a total of over 500 residents. All persons who are not terminally ill, are able to be interviewed and sign informed consent are included. For cognitively impaired persons family proxies will be approached to provide outcome information. The Disease Management Model consists of several elements: (1) Trained staff carries out a multidimensional assessment of the patients functional health and care needs with the interRAI Long Term Care Facilities instrument (LTCF). Computerization of the LTCF produces immediate identification of problem areas and thereby guides individualized care planning. (2) The assessment outcomes are discussed in a Multidisciplinary Meeting (MM) with the nurse, primary care physician, nursing home physician and Psychotherapist and if necessary other members of the care team. The MM presents individualized care plans to manage or treat modifiable disabilities and risk factors. (3) Consultation by an nursing home physician and psychotherapist is offered to the frailest residents at risk for nursing home admission (according to the interRAI LTCF). Outcome measures are Quality of Care indicators (LTCF based), Quality Adjusted Life Years (Euroqol), Functional health (SF12, COOP-WONCA), Disability (GARS), Patients care satisfaction (QUOTE), hospital and nursing home days and mortality, health care utilization and costs.</p> <p>Discussion</p> <p>This design is unique because no earlier studies were performed to evaluate the effects and costs of this Disease Management Model for disabled persons in homes for the elderly on functional health and quality of care.</p> <p>Trail registration number</p> <p>ISRCTN11076857</p>http://www.biomedcentral.com/1472-6963/8/143 |
| spellingShingle | Ribbe Miel W Frijters Dinnus H van Hout Hein PJ Boorsma Marijke Nijpels Giel The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial BMC Health Services Research |
| title | The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial |
| title_full | The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial |
| title_fullStr | The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial |
| title_full_unstemmed | The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial |
| title_short | The cost-effectiveness of a new disease management model for frail elderly living in homes for the elderly, design of a cluster randomized controlled clinical trial |
| title_sort | cost effectiveness of a new disease management model for frail elderly living in homes for the elderly design of a cluster randomized controlled clinical trial |
| url | http://www.biomedcentral.com/1472-6963/8/143 |
| work_keys_str_mv | AT ribbemielw thecosteffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT frijtersdinnush thecosteffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT vanhoutheinpj thecosteffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT boorsmamarijke thecosteffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT nijpelsgiel thecosteffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT ribbemielw costeffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT frijtersdinnush costeffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT vanhoutheinpj costeffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT boorsmamarijke costeffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial AT nijpelsgiel costeffectivenessofanewdiseasemanagementmodelforfrailelderlylivinginhomesfortheelderlydesignofaclusterrandomizedcontrolledclinicaltrial |